Diego Miralles's most recent trade in Contineum Therapeutics Inc. - Ordinary Shares - Class A was a trade of 14,750 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 26, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Contineum Therapeutics Inc... | Diego Miralles | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2025 | 14,750 | 14,750 | - | - | Stock Option (right to buy) | |
| Artiva Biotherapeutics Inc | Diego Miralles | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2025 | 13,750 | 13,750 | - | - | Director Stock Option (Right to Buy) | |
| Contineum Therapeutics Inc... | Diego Miralles | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2025 | 29,500 | 29,500 | - | - | Stock Option (right to buy) | |
| NeuBase Therapeutics Inc | Diego Miralles | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2020 | 14,634 | 14,634 | - | - | Stock option (right to buy) |